Sarepta Therapeutics (SRPT)
Healthcare · Biotechnology
3 members of Congress have disclosed 7 trades in Sarepta Therapeutics (SRPT) since 2023: 3 buys and 4 sales. The most recent was disclosed on May 6, 2025.
- Trades disclosed
- 7
- Members trading
- 3
- Buys / sells
- 3 / 4
- Reported value
- $35K–$175K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at SRPT
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded SRPT
- Rep. Josh Gottheimer (D-NJ-5)2 buys · 1 sale21Aug 21, 2023
- Rep. Daniel S. Goldman (D-NY-10)1 buy · 2 sales12May 19, 2023
- Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)0 buys · 1 sale01May 6, 2025
All trades
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Apr 14, 2025 · disclosed May 6, 2025
- Aug 21, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Sarepta Therapeutics SRPT
$1K–$15K · Traded Jul 14, 2023 · disclosed Aug 21, 2023 · Joint
- Jul 11, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Jun 13, 2023 · disclosed Jul 11, 2023 · Joint
- May 19, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Sold Sarepta Therapeutics SRPT
$15K–$50K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Apr 20, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Sarepta Therapeutics SRPT
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 17, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Bought Sarepta Therapeutics SRPT
$15K–$50K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Feb 24, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.